BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18774699)

  • 1. Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers.
    Angelucci F; Ricci V; Spalletta G; Pomponi M; Tonioni F; Caltagirone C; Bria P
    Eur Neuropsychopharmacol; 2008 Dec; 18(12):882-7. PubMed ID: 18774699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor.
    Angelucci F; Ricci V; Pomponi M; Conte G; Mathé AA; Attilio Tonali P; Bria P
    J Psychopharmacol; 2007 Nov; 21(8):820-5. PubMed ID: 17715210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse.
    Jockers-Scherübl MC; Danker-Hopfe H; Mahlberg R; Selig F; Rentzsch J; Schürer F; Lang UE; Hellweg R
    Neurosci Lett; 2004 Nov; 371(1):79-83. PubMed ID: 15500971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse.
    Jockers-Scherübl MC; Rentzsch J; Danker-Hopfe H; Radzei N; Schürer F; Bahri S; Hellweg R
    Neurosci Lett; 2006 Jun; 400(3):262-6. PubMed ID: 16540246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms.
    Angelucci F; Ricci V; Martinotti G; Palladino I; Spalletta G; Caltagirone C; Bria P
    Addict Biol; 2010 Jul; 15(3):365-7. PubMed ID: 20477754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic amphetamine treatment reduces NGF and BDNF in the rat brain.
    Angelucci F; Gruber SH; El Khoury A; Tonali PA; Mathé AA
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):756-62. PubMed ID: 17434716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence.
    Lee BC; Choi IG; Kim YK; Ham BJ; Yang BH; Roh S; Choi J; Lee JS; Oh DY; Chai YG
    Alcohol; 2009 Jun; 43(4):265-9. PubMed ID: 19560628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nerve growth factor and brain-derived neurotrophic factor: a possible etiopathogenic role in sensorineural hearing loss. Preliminary data].
    Salvinelli F; Antonelli A; Stampachiacchiere B; Bianchi di Castelbianco F; Casale M; D'Ascanio L; Greco F; Aloe L
    Ann Ist Super Sanita; 2003; 39(2):189-94. PubMed ID: 14587217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress.
    Schulte-Herbrüggen O; Fuchs E; Abumaria N; Ziegler A; Danker-Hopfe H; Hiemke C; Hellweg R
    J Neurosci Res; 2009 Aug; 87(11):2551-60. PubMed ID: 19360902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
    Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
    Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis.
    Raap U; Werfel T; Goltz C; Deneka N; Langer K; Bruder M; Kapp A; Schmid-Ott G; Wedi B
    Allergy; 2006 Dec; 61(12):1416-8. PubMed ID: 17073871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neurotrophins--a study on the time course and influencing factors in a large old age sample.
    Ziegenhorn AA; Schulte-Herbrüggen O; Danker-Hopfe H; Malbranc M; Hartung HD; Anders D; Lang UE; Steinhagen-Thiessen E; Schaub RT; Hellweg R
    Neurobiol Aging; 2007 Sep; 28(9):1436-45. PubMed ID: 16879899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and sputum neurotrophin levels in chronic persistent cough.
    Chaudhuri R; McMahon AD; McSharry CP; Macleod KJ; Fraser I; Livingston E; Thomson NC
    Clin Exp Allergy; 2005 Jul; 35(7):949-53. PubMed ID: 16008683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotrophins in chronic cough: association with asthma but not with cough severity.
    Koskela HO; Purokivi MK; Romppanen J
    Clin Respir J; 2010 Jan; 4(1):45-50. PubMed ID: 20298417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Music exposure differentially alters the levels of brain-derived neurotrophic factor and nerve growth factor in the mouse hypothalamus.
    Angelucci F; Ricci E; Padua L; Sabino A; Tonali PA
    Neurosci Lett; 2007 Dec; 429(2-3):152-5. PubMed ID: 17980967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia.
    Rizos EN; Michalopoulou PG; Siafakas N; Stefanis N; Douzenis A; Rontos I; Laskos E; Kastania A; Zoumpourlis V; Lykouras L
    Neuropsychobiology; 2010; 62(2):87-90. PubMed ID: 20523079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse.
    Frota ER; Rodrigues DH; Donadi EA; Brum DG; Maciel DR; Teixeira AL
    Neurosci Lett; 2009 Aug; 460(2):130-2. PubMed ID: 19477225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of serum brain-derived neurotrophic factor level with other markers of disease severity in patients with atopic dermatitis.
    Namura K; Hasegawa G; Egawa M; Matsumoto T; Kobayashi R; Yano T; Katoh N; Kishimoto S; Ohta M; Obayashi H; Ose H; Fukui M; Nakamura N; Yoshikawa T
    Clin Immunol; 2007 Feb; 122(2):181-6. PubMed ID: 17161975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.
    Martinotti G; Di Iorio G; Marini S; Ricci V; De Berardis D; Di Giannantonio M
    J Biol Regul Homeost Agents; 2012; 26(3):347-56. PubMed ID: 23034254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.